Coherus BioSciences Number Of Shares Shorted vs. Current Valuation
| CHRS Stock | USD 0.88 0.03 3.53% |
For Coherus BioSciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Coherus BioSciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Coherus BioSciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Coherus BioSciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Coherus BioSciences over time as well as its relative position and ranking within its peers.
Coherus |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Coherus BioSciences. If investors know Coherus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Coherus BioSciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.76) | Earnings Share (0.38) | Revenue Per Share 2.819 | Quarterly Revenue Growth 0.107 | Return On Assets (0.16) |
The market value of Coherus BioSciences is measured differently than its book value, which is the value of Coherus that is recorded on the company's balance sheet. Investors also form their own opinion of Coherus BioSciences' value that differs from its market value or its book value, called intrinsic value, which is Coherus BioSciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Coherus BioSciences' market value can be influenced by many factors that don't directly affect Coherus BioSciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Coherus BioSciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Coherus BioSciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Coherus BioSciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Coherus BioSciences Current Valuation vs. Number Of Shares Shorted Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Coherus BioSciences's current stock value. Our valuation model uses many indicators to compare Coherus BioSciences value to that of its competitors to determine the firm's financial worth. Coherus BioSciences is number one stock in number of shares shorted category among its peers. It is rated third in current valuation category among its peers reporting about 7.59 of Current Valuation per Number Of Shares Shorted. Comparative valuation analysis is a catch-all technique that is used if you cannot value Coherus BioSciences by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Coherus Current Valuation vs. Number Of Shares Shorted
Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
Coherus BioSciences |
| = | 27.96 M |
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Coherus BioSciences |
| = | 212.17 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Coherus Current Valuation vs Competition
Coherus BioSciences is rated third in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is currently estimated at about 3.88 Billion. Coherus BioSciences holds roughly 212.17 Million in current valuation claiming about 5% of equities under Health Care industry.
Coherus BioSciences Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Coherus BioSciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Coherus BioSciences will eventually generate negative long term returns. The profitability progress is the general direction of Coherus BioSciences' change in net profit over the period of time. It can combine multiple indicators of Coherus BioSciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -248 K | -260.4 K | |
| Operating Income | -193.2 M | -183.5 M | |
| Income Before Tax | -238.3 M | -226.4 M | |
| Total Other Income Expense Net | -45.1 M | -42.8 M | |
| Net Loss | -237.9 M | -226 M | |
| Income Tax Expense | -380 K | -361 K | |
| Net Loss | -237.9 M | -226 M | |
| Non Operating Income Net Other | -2.8 M | -2.9 M | |
| Net Loss | -262.6 M | -249.4 M | |
| Interest Income | 20.2 M | 21.3 M | |
| Net Interest Income | -40.5 M | -38.5 M | |
| Change To Netincome | 95.4 M | 68.6 M | |
| Net Loss | (2.53) | (2.65) | |
| Income Quality | 0.74 | 0.52 | |
| Net Income Per E B T | 1.00 | 0.81 |
Coherus Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Coherus BioSciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Coherus BioSciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Coherus BioSciences' important profitability drivers and their relationship over time.
Use Coherus BioSciences in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Coherus BioSciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coherus BioSciences will appreciate offsetting losses from the drop in the long position's value.Coherus BioSciences Pair Trading
Coherus BioSciences Pair Trading Analysis
The ability to find closely correlated positions to Coherus BioSciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Coherus BioSciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Coherus BioSciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Coherus BioSciences to buy it.
The correlation of Coherus BioSciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Coherus BioSciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Coherus BioSciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Coherus BioSciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Coherus BioSciences position
In addition to having Coherus BioSciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Rentals Thematic Idea Now
Rentals
Companies providing rental and leasing services to public and business. The Rentals theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Rentals Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Coherus Stock Analysis
When running Coherus BioSciences' price analysis, check to measure Coherus BioSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coherus BioSciences is operating at the current time. Most of Coherus BioSciences' value examination focuses on studying past and present price action to predict the probability of Coherus BioSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coherus BioSciences' price. Additionally, you may evaluate how the addition of Coherus BioSciences to your portfolios can decrease your overall portfolio volatility.